Results 41 to 50 of about 6,851,925 (312)

Mortalidad por cáncer oral en Chile entre los años 2002-2012 [PDF]

open access: yes, 2015
Tesis (Cirujano Dentista, Grado de Magíster en Ciencias Odontológicas)En Chile desde 1970 el cáncer es la 2a causa de muerte, siendo el cáncer oral un problema de salud de alcance mundial, según lo indica la OMS.
Candia Rojas, Jorge, Kraemer Meza, Kim
core  

Stereotactic Body Radiation Therapy for Pediatric, Adolescent, and Young Adult Patients With Osteosarcoma: Local Control Outcomes With Dosimetric Analysis

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Objectives Osteosarcoma is a radioresistant tumor that may benefit from stereotactic body radiation therapy (SBRT) for locoregional control in metastatic/recurrent disease. We report institutional practice patterns, outcomes, toxicity, and failures in osteosarcoma patients treated with SBRT.
Jenna Kocsis   +13 more
wiley   +1 more source

Frecuencia y distribucion de cancer oral en el Hospital Regional de Talca y Hospital Base de Curico entre los años 1991 y 1992 [PDF]

open access: yes, 2003
96 p.Se realizó un estudio descriptivo de cáncer oral en el Hospital Regional de Talca y Hospital Base de Curico entre los anos 1991 a 2002.
Melendez Meza, Marcela Paz   +1 more
core  

Prognostic Impact of Treatment Modalities, Including Targeted Compartmental Radio‐Immunotherapy, in a Cohort of Neuroblastoma Patients With CNS Metastases at Relapse

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Neuroblastoma (NB) with central nervous system (CNS) metastases is rare at diagnosis, but occurs more often during relapse/progression. Patients with CNS metastases face a dismal prognosis, with no standardized curative treatment available.
Vicente Santa‐Maria Lopez   +13 more
wiley   +1 more source

Alimentos contra el cáncer oral [PDF]

open access: yes, 2015
El cáncer oral representa el 5% de todas las neoplasias y el 30% de los cánceres de cabeza y cuello. El porcentaje de supervivencia a los 5 años es de tan sólo el 25%, por lo que el diagnóstico y tratamiento precoces pueden salvar muchas vidas.
Chimenos Küstner, Eduardo   +2 more
core  

Survival outcomes after treatment of cancer of the oral cavity (1985-2015).

open access: yesOral Oncology, 2019
OBJECTIVES To present treatment results of oral squamous cell carcinoma (OSCC) at a tertiary cancer care center from 1985 to 2015. MATERIALS AND METHODS A total of 2082 patients were eligible for this study. Main outcomes measured were overall survival
D. Zanoni   +6 more
semanticscholar   +1 more source

The Oral Microbiome and Cancer

open access: yesFrontiers in Immunology, 2020
There is mounting evidence that members of the human microbiome are highly associated with a wide variety of cancer types. Among oral cancers, oral squamous cell carcinoma (OSCC) is the most prevalent and most commonly studied, and it is the most common ...
M. Irfan   +2 more
semanticscholar   +1 more source

The newfound relationship between extrachromosomal DNAs and excised signal circles

open access: yesFEBS Letters, EarlyView.
Extrachromosomal DNAs (ecDNAs) contribute to the progression of many human cancers. In addition, circular DNA by‐products of V(D)J recombination, excised signal circles (ESCs), have roles in cancer progression but have largely been overlooked. In this Review, we explore the roles of ecDNAs and ESCs in cancer development, and highlight why these ...
Dylan Casey, Zeqian Gao, Joan Boyes
wiley   +1 more source

ctuaciones sobre la autonomía, información y participación de los pacientes con cáncer colorrectal en un Hospital de Día de Oncología Médica [PDF]

open access: yes, 2010
Introducción: La Ley 41/2002, de Autonomía del Paciente, obliga a informar para que el paciente participe activamente en la toma de decisiones respecto al diagnóstico y al tratamiento de la enfermedad.
Aranda, Recuerdo   +6 more
core   +2 more sources

Inhibiting stearoyl‐CoA desaturase suppresses bone metastatic prostate cancer by modulating cellular stress, mTOR signaling, and DNA damage response

open access: yesFEBS Letters, EarlyView.
Bone metastasis in prostate cancer (PCa) patients is a clinical hurdle due to the poor understanding of the supportive bone microenvironment. Here, we identify stearoyl‐CoA desaturase (SCD) as a tumor‐promoting enzyme and potential therapeutic target in bone metastatic PCa.
Alexis Wilson   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy